The purpose of this RFA is to stimulate the development of high-quality, multi-principal investigator (PI) program project grants that will move forward to nationally-funded grant awards.
The purpose of this RFA is to stimulate the development of high-quality, multi-principal investigator (PI) (minimum of three PIs) program project grants that will move forward to nationally-funded grant awards. Projects with translational potential are encouraged, but not mandatory. Inter-programmatic teams are highly encouraged. HCC leadership anticipates distributing awards up to $150,000 per year for up to two years. Year two is contingent on the submission of an annual progress report (month 11) showing successful completion of project goals. PIs are expected to seek regulatory approvals [e.g., IACUC and IRB] in a timely manner. Any extensions will require prior approval. Please note that funding cannot be released until all applicable human and animal subject protocols have been approved and copies have been sent to firstname.lastname@example.org. Inclusion of projects from an outside institution are permitted with certain restrictions. Please contact HCC administration if you wish to explore this option. All publications derived from this funding must site the HCC’s Cancer Center Support Grant (P30 CA138313).
Full applications are due by 5:00pm on Friday, August 3rd, 2018. Please send one PDF file of the application packet via email to Kimrey Lloyd (email@example.com). Applications will be peer-reviewed by mid-September. Notifications of awards will be made in early October, 2018. The earliest anticipated start date is Noevember 1, 2018, depending on the status of human and animal studies protocol approvals.
Each full application will be assigned to both internal and external reviewers who have substantial expertise in cancer research and in reviewing grants programmatic/team science grants.
Review criteria will include:
Applicants are strongly encouraged to consult HCC BSR Biostatisticians when developing the research design and methods of their proposals (Dr. Betsy Hill, Director, BSR).